BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22417860)

  • 21. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia.
    Stachel D; Albert M; Meilbeck R; Paulides M; Schmid I
    Oncol Rep; 2007 Jan; 17(1):147-52. PubMed ID: 17143492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.
    Negaard HF; Iversen N; Bowitz-Lothe IM; Sandset PM; Steinsvik B; Ostenstad B; Iversen PO
    Leukemia; 2009 Jan; 23(1):162-9. PubMed ID: 18800145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies.
    Gupta P; Khurana N; Singh T; Gupta D; Dhingra KK
    Hematology; 2009 Feb; 14(1):16-21. PubMed ID: 19154660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
    Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.
    Kuzu I; Beksac M; Arat M; Celebi H; Elhan AH; Erekul S
    Leuk Lymphoma; 2004 Jun; 45(6):1185-90. PubMed ID: 15359999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
    Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
    Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
    Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
    Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
    Koh YW; Han JH; Yoon DH; Suh C; Huh J
    Ann Hematol; 2017 Nov; 96(11):1883-1890. PubMed ID: 28842748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction.
    Koomagi R; Zintl F; Sauerbrey A; Volm M
    Clin Cancer Res; 2001 Nov; 7(11):3381-4. PubMed ID: 11705851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
    Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
    Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
    Kasparová P; Smolej L
    Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.